Warning: Attempt to read property "ID" on null in /usr/home/sniznik/domains/celonpharma.com/public_html/wp-content/themes/celon/assets/functions/cleanup.php on line 74

Warning: Attempt to read property "ID" on null in /usr/home/sniznik/domains/celonpharma.com/public_html/wp-content/themes/celon/assets/functions/cleanup.php on line 74
{"version":"1.0","provider_name":"Celon Pharma","provider_url":"https:\/\/celonpharma.com\/en\/","title":"We are at the EACR in Barcelona - Celon Pharma","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vFgsOxftj0\"><a href=\"https:\/\/celonpharma.com\/en\/meet-us-on-eacr-in-barcelona\/\">We are at the EACR in Barcelona<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/celonpharma.com\/en\/meet-us-on-eacr-in-barcelona\/embed\/#?secret=vFgsOxftj0\" width=\"600\" height=\"338\" title=\"&#8220;We are at the EACR in Barcelona&#8221; &#8212; Celon Pharma\" data-secret=\"vFgsOxftj0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/celonpharma.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"You can meet us at the The European Association for Cancer Research conference in Barcelona (7-10 July), where we present the results of our studies: NPM-ALK I1171T mutation confers resistance to crizotinib in anaplastic large cell lymphoma. Differential gene transcription response to the treatment with JAK2 inhibitors \u2013 Ruxolitinib, SAR302503 and LY2784544. Gene silencing ofRead more &raquo;"}